BRCA1 and ovarian carcinoma: <b>Conclusions:</b> The article summarizes the growing number of genetic modifiers of ovarian cancer risk among <i>BRCA1/2</i> carriers and highlights their potential to improve individualized risk assessment, enhance patient stratification, support personalized prevention and surveillance strategies, deepen the understanding of disease biology, and identify potential therapeutic targets.